Diagnostic methods currently used for bladder cancer are cystoscopy and urine cytology.
Cystoscopy is an invasive tool and has low sensitivity for carcinoma in situ. Urine cytology is …

Bladder cancer (BC) is the second highest morbid malignancy of the urinary tract and the
fifth most common cancer worldwide. BC is highly malignant with significant morbidity and …

Cardiac hypertrophy has been a high prevalence rate throughout the world. It has posed a
big threat to public health due to limited therapeutic approaches. Previous studies showed …

Background Urothelial bladder cancer (BLCA) is one of the most common internal
malignancies worldwide with poor prognosis. This study aims to explore effective prognostic …

The current study aimed to evaluate the expression and specific role of miR‑26a‑5p in the
progression of bladder cancer (BC). Reverse transcription‑quantitative polymerase chain …

A novel, highly selective biomarker is urgently needed to predict and monitor triple-negative
breast cancer (TNBC) because targeting molecules are not currently available. Although …

Background/Aims: microRNA (miR)-374a plays a crucial role in cancer progression by
promoting the metastasis and proliferation of various types of malignant tumors. Because its …

Bladder urothelial carcinoma is a malignant tumor with a high incidence in the uropoietic
system. Considerable studies have shown that long noncoding RNA (lncRNA) plays an …

Triple‐negative breast cancer (TNBC) is a highly aggressive tumour that lacks marker for
targeted diagnosis. Recently, it was reported that toll‐like receptor 5 (TLR5) was associated …

Acute myeloid leukemia (AML) is a widely prevalent disease worldwide and poses a large
threat to public health. Previous studies have shown that AML is associated with cytogenetic …